Status:
UNKNOWN
Cutaneous Silent Period and Spasticity
Lead Sponsor:
Marmara University
Conditions:
Stroke
Eligibility:
All Genders
18-80 years
Brief Summary
The cutaneous silent period (CSP) is a brief transient suppression of the voluntary muscle contraction that follows a noxious cutaneous nerve stimulation. Studies in patients with central disorders of...
Detailed Description
The cutaneous silent period (CSP) is a brief transient suppression of the voluntary muscle contraction that follows a noxious cutaneous nerve stimulation. Studies in patients with central disorders of...
Eligibility Criteria
Inclusion
- First ever time stroke
- Time since stroke \>1 month
- Being able to understand the instructions (mini mental test score\>24)
Exclusion
- Diseases which might affect CSP parameters (Parkinsonism, restless leg syndrome, carpal tunel syndrome etc.)
- Autonomic nervous system disease
- Antispasticity medication use
- Hemiplegic shoulder pain
- Botulinum toxin injection within 6 months
Key Trial Info
Start Date :
July 1 2018
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
February 1 2019
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT03421509
Start Date
July 1 2018
End Date
February 1 2019
Last Update
July 3 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Marmara University School of Medicine Department of Physical Medicine and Rehabilitation
Istanbul, Turkey (Türkiye), 34899